#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3117611	F	Reduction in triglyceride level in Zucker fa/fa rat plasma at 75 mg/kg, po qd for 5 days relative to vehicle-treated control control	Rattus norvegicus	1		organism-based format	Scientific Literature
2.	ALA3117612	F	Reduction in insulin level in Zucker fa/fa rat plasma at 75 mg/kg, po qd for 5 days relative to vehicle-treated control control	Rattus norvegicus	1		organism-based format	Scientific Literature
3.	ALA3117613	F	Reduction in free fatty acid level in Zucker fa/fa rat plasma at 75 mg/kg, po qd for 5 days relative to vehicle-treated control control	Rattus norvegicus	1		organism-based format	Scientific Literature
4.	ALA3117614	F	Antihypertensive activity in dosed SHR NCrl rat assessed as decrease in diastolic blood pressure at 10 mg/kg, po administered daily for 12 days relative to vehicle-treated control control	Rattus norvegicus	1		organism-based format	Scientific Literature
5.	ALA3117615	F	Antihypertensive activity in dosed SHR NCrl rat assessed as decrease in diastolic blood pressure at 10 mg/kg, po administered daily for 12 days relative to baseline control	Rattus norvegicus	1		organism-based format	Scientific Literature
6.	ALA3117616	F	Antihypertensive activity in dosed SHR NCrl rat assessed as decrease in systolic blood pressure at 10 mg/kg, po administered daily for 12 days relative to vehicle-treated control control	Rattus norvegicus	1		organism-based format	Scientific Literature
7.	ALA3117617	F	Antihypertensive activity in dosed SHR NCrl rat assessed as decrease in systolic blood pressure at 10 mg/kg, po administered daily for 12 days relative to baseline control	Rattus norvegicus	1		organism-based format	Scientific Literature
8.	ALA3117618	A	Oral bioavailability in Zucker fa/fa rat at 30 mg/kg	Rattus norvegicus	1		organism-based format	Scientific Literature
9.	ALA3117619	A	AUC in Zucker fa/fa rat at 30 mg/kg, po	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA3117620	A	Clearance in Zucker fa/fa rat at 5.2 mg/kg, iv	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA3117621	A	Volume of distribution at steady state in Zucker fa/fa rat 5.2 mg/kg, iv	Rattus norvegicus	1		organism-based format	Scientific Literature
12.	ALA3117622	A	Half life in Zucker fa/fa rat at 5.2 mg/kg, iv	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA3117623	A	AUC in Zucker fa/fa rat at 5.2 mg/kg, iv	Rattus norvegicus	1		organism-based format	Scientific Literature
14.	ALA3117624	B	Partial agonist activity at mouse PPARgamma expressed in CV-1 cells by reporter gene assay relative to rosiglitazone	Mus musculus	2		cell-based format	Scientific Literature
15.	ALA3117625	B	Partial agonist activity at mouse PPARgamma expressed in CV-1 cells by reporter gene assay	Mus musculus	2		cell-based format	Scientific Literature
16.	ALA3117626	B	Partial agonist activity at human PPARgamma expressed in CV-1 cells by reporter gene assay relative to rosiglitazone	Homo sapiens	2		cell-based format	Scientific Literature
17.	ALA3117627	B	Partial agonist activity at human PPARgamma expressed in CV-1 cells by reporter gene assay	Homo sapiens	2		cell-based format	Scientific Literature
18.	ALA3117628	B	Agonist activity at mouse PPARdelta expressed in CV-1 cells by reporter gene assay	Mus musculus	8		cell-based format	Scientific Literature
19.	ALA3117630	B	Agonist activity at mouse PPARalpha expressed in CV-1 cells by reporter gene assay	Mus musculus	11		cell-based format	Scientific Literature
20.	ALA3117635	B	Antagonist activity at human AT1 receptor expressed in CHO cells measured after overnight incubation by luciferase reporter gene assay	Homo sapiens	15		cell-based format	Scientific Literature